The smartest presence in the room could very well be the computer. With the rise of large language models (LLMs), the exam room now includes an unprecedented repository of knowledge and computational power.
If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.
This article was published orginally in Fortune and is authored by Arthur Allen and republished with permission from KHN (@khnews).
The drug industry, patient advocates,...